There is evidence to suggest that Angiotensin converting enzyme inhibitors can reduce the risk of Alzheimer’s disease in the absence of apolipoprotein E4 allele [68]. This evidence concerns the gene ACE and early-onset autosomal dominant Alzheimer disease.